Senior insider sale
Chief Business Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$3.50M
100K shares
What this filing means
KREMPA DAVID plans to sell 100K shares of ETON PHARMACEUTICALS, INC. valued at approximately $3.50M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/22/2026ACC: 0001974078-26-000191
Officer· Chief Business Officer
Since Mar 2023
100K
Shares to sell
$3.50M
Approx. market value
100K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months6
Options
Cash
5/22/2026
37.79KOptions
Cash
5/22/2026
25KOptions
Cash
5/22/2026
25KRSU
Cash
10/10/2024
549.00RSU
Cash
7/12/2024
10KRSU
Cash
6/10/2024
1.66KTotal acquired100K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/22/2026 | Options Cash | 37.79K | — |
5/22/2026 | Options Cash | 25K | — |
5/22/2026 | Options Cash | 25K | — |
10/10/2024 | RSU Cash | 549.00 | — |
7/12/2024 | RSU Cash | 10K | — |
6/10/2024 | RSU Cash | 1.66K | — |
| Total | 100K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
100K
Market value
$3.50M
5/22/2026
Total
Units
100K
Value
$3.50M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/22/2026 | 100K | $3.50M | Nasdaq | Planned |
| Total | 100K | $3.50M | ||